ArticleOncotarget2018

Carboplatin in combination with weekly Paclitaxel as first-line therapy in patients with recurrent/metastatic head and neck squamous cell carcinoma unfit to EXTREME schedule.

Adeline Pêtre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.